This prevents condensation from forming on the rubber stopper, which can introduce moisture and potential contaminants
To view a copy of this licence, visit About this article Cite this article Sawicka-Gutaj, N., Gruszczyski, D., Nijakowski, K
Standard monitoring includes: Thyroid-stimulating hormone (TSH) levels 6-8 weeks after starting or adjusting semaglutide, then every 6-12 months once stable Free T4 levels if TSH results are abnormal or symptoms suggest thyroid dysfunction More frequent monitoring with oral semaglutide due to the known pharmacokinetic interaction Additional testing if you experience symptoms of hypo- or hyperthyroidism Diabetes and Weight Parameters require ongoing assessment: Hemoglobin A1C every 3 months if therapy changes or not at goal
Participants who lost 15 percent or more of their body weight saw larger reductions in systolic blood pressure (around 10 mmHg versus 4 mmHg in those losing less) and diastolic pressure (around 4 mmHg versus 1 mmHg), with greater falls in C-reactive protein and non-HDL cholesterol as well (Patient Care Online, 2026)
Clinical trial results: what the data shows Retatrutide has demonstrated impressive results in clinical trials, though it's important to understand these are still research findings, not real-world outcomes
